Chemoinformaics analysis of n-acetyldiaminobutyric-acid
| Molecular Weight | 198.306 | nRot | 9 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 0 |
| Exact Molecular Weight | 198.162 | nRing | 0 |
| Solubility: LogS | -6.559 | nHRing | 0 |
| Solubility: LogP | 7.138 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 36.3134 |
| nHD | 1 | BPOL | 22.9386 |
| QED | 0.395 |
| Synth | 2.339 |
| Natural Product Likeliness | 0.894 |
| NR-PPAR-gamma | 0.032 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.646 |
| MDCK | 0.0000117 |
| BBB | 0.094 |
| PPB | 0.980471 |
| VDSS | 2.957 |
| FU | 0.0175542 |
| CYP1A2-inh | 0.342 |
| CYP1A2-sub | 0.194 |
| CYP2c19-inh | 0.361 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.141 |
| CYP2c9-sub | 0.929 |
| CYP2d6-inh | 0.061 |
| CYP2d6-sub | 0.059 |
| CYP3a4-inh | 0.171 |
| CYP3a4-sub | 0.054 |
| CL | 5.333 |
| T12 | 0.128 |
| hERG | 0.156 |
| Ames | 0.007 |
| ROA | 0.018 |
| SkinSen | 0.952 |
| Carcinogencity | 0.037 |
| EI | 0.931 |
| Respiratory | 0.501 |
| NR-Aromatase | 0.033 |
| Antiviral | Yes |
| Prediction | 0.604668 |